Friday, May 22, 2020
|
|
PNEC |
|
| 7:00 a.m. |
Continental Breakfast With the Exhibitors and Industry Session |
|
| 7:55 a.m. |
Welcoming Remarks |
Niten Singh, MD |
|
Session I: Aortic – Modern Management |
Moderators: Andres Schanzer, MD and Benjamin Starnes, MD |
| 8:00 a.m. |
Appropriateness in Aneurysm Surgery: How Not To Do It! |
Thomas Forbes, MD |
| 8:10 a.m. |
Complex EVAR and Advanced Imaging Guidance Now and in the Future |
Marc Schermerhorn, MD |
| 8:20 a.m. |
FEVAR for Failed EVAR: Findings from the IDE Consortium |
Andres Schanzer, MD |
| 8:30 a.m. |
Type II Endoleaks After EVAR: Embolization, Sac Injection vs. Revision |
Mark Conrad, MD |
| 8:40 a.m. |
What Everyone Should Know About Genetically Triggered Aortic Pathologies |
Sherene Shalhub, MD |
| 8:50 a.m. |
Open vs. Endovascular Procedures in Patients With Connective Tissue Disorders: How I Do It? |
Peter Rossi, MD |
| 9:00 a.m. |
Open TAAA Repair: Is it an Operation of the Past and How Do We Train the Next Generation to Do This? |
Kelli Brown, MD |
| 9:10 a.m. |
Innovation and a Glimpse at the Future of Aortic Interventions |
Benjamin Starnes, MD |
| 9:20 a.m. |
Management of Visceral Artery Aneurysms: What Do the Guidelines State |
Dawn Coleman, MD |
| 9:30 a.m. |
Impact of Medical Management on Inhibition of Growth of Small AAA’s: Is There is Evidence That It Works? |
Anders Wanhainen, MD |
| 9:40 a.m. |
Panel Discussion and Audience Questions |
|
| 10:00 a.m. |
Refreshment Break and Visit With the Exhibitors |
|
|
Session II: Lower Extremity |
Moderators: Chris Abularrage, MD and Niten Singh, MD |
| 10:30 a.m. |
Amputation Trends in CLTI: Are We Making Progress? |
Misty Dawn Humphries, MD |
| 10:40 a.m. |
Future of DCB and DES and What is the Status a Year Later? |
Peter Schneider, MD |
| 10:50 a.m. |
The Future of Tibial Interventions: What Works, What Does Not and What Does the Future Hold? |
John Laird, MD |
| 11:00 a.m. |
Socioeconomic Factors Affecting Outcomes in PAD |
Ravi Rajani, MD |
| 11:10 a.m. |
Multidisciplinary Approach to Limb Salvage: It Works and How to Embrace It and Not Fight It |
Vincent Rowe, MD |
| 11:20 a.m. |
Results of Utilizing Coronary Drug-Eluting Stents in LE Occlusive Disease and Failing Bypasses: Do They Work? |
Chris Abularrage, MD |
| 11:30 a.m. |
Navigating the Options Available for Femoropopliteal Occlusive Disease: How to Optimize Therapy in a Cost-Conscious Environment |
Don Jacobs, MD |
| 11:40 a.m. |
Pedal Acceleration TIME (PAT): It Can Change Your Approach to Limb Salvage |
Jill Sommerset, RVT |
| 11:50 a.m. |
Trials and Tribulations of Managing a Large Multicenter CLI Trial: Lessons Learned |
Matt Menard, MD |
| 12:00 p.m. |
Panel Discussion and Audience Questions |
|
| 12:15 p.m. |
Lunch Break, Visit Exhibits and Industry Session |
|
| 12:15 p.m. – 1:00 p.m. |
Resident Competition – EVAR Planning |
|
| 1:00 p.m.- 2:30 p.m. |
Concurrent Focus Session: Updates on Vascular Surgery for Allied Health Professionals |
Moderators: Elina Quiroga, MD and Brenda Allen Kline, ARNP |
|
Session III: Venous |
Moderators: Mark Meissner, MD and Cynthia Shortell, MD |
| 1:00 p.m. |
New Developments in the Treatment of Major Venolymphatic Malformations |
Cynthia Shortell, MD |
| 1:10 p.m. |
Pelvic Venous Disorders: How to Understand and Treat Them |
Mark Meissner, MD |
| 1:20 p.m. |
|
Steven Dean, MD |
| 1:30 p.m. |
Venous Aneurysm: When to Operate, When to Watch and the Role of Anticoagulation |
Bill Marston, MD |
| 1:45 p.m. |
One Treatment Per Leg Per Life: How to Optimize Treatment in the Current Payor Environment? |
John Kaufman, MD |
| 1:55 p.m. |
To Accredit or Not Accredit: Benefits of and Strategies of Certification |
David Dawson, MD |
| 2:05 p.m. |
Perforators: Where is the Intersection of Guidelines, Real Life and Technology |
David Rigberg, MD |
| 2:15 p.m. |
Panel Discussion and Audience Questions |
|
| 2:45 p.m. – 4:05 p.m. |
Concurrent Focus Session: Limb Preservation and Wound Care |
Moderator: Joseph Fiorito, DPM |
|
Session IV: Physician Practice |
Moderators: David Deaton, MD and Sean Roddy, MD |
| 2:30 p.m. |
Demographic Trends in Vascular Disease and How It Will Affect Future Practice |
Marc Bonaca, MD |
| 2:40 p.m. |
Surgeon Volume vs. Experience in AAA: Which One Matters More |
David Stone, MD |
| 2:50 p.m. |
Financial and Quality (PSI-Patient Safety Indicators) Impact on Vascular Surgery Documentation |
Francisco Aiello, MD |
| 3:00 p.m. |
Identifying the High Risk Asymptomatic Carotid Patient: What Should We Look For? |
Wei Zhou, MD |
| 3:10 p.m. |
Implications of Diabetes in the Future of Vascular Disease |
Philip Goodney, MD |
| 3:20 p.m. |
Effectiveness of Repeated Interventions on HD Access |
Benjamin Brooke, MD |
| 3:30 p.m. |
Office Based Lab: Are These Facilities More Efficient to Treat Patients? |
Zak Arthurs, MD |
| 3:40 p.m. |
Update on Coding and Reimbursement |
Sean Roddy, MD |
| 3:50 p.m. |
Panel Discussion and Audience Questions |
|
| 4:05 p.m. |
Refreshment Break and Visit Exhibits |
|
|
Session V: Technical Pearls and Debate |
Moderators: Zak Arthurs, MD and Matt Sweet, MD |
| 4:35 p.m. |
Treatment of Renal and Splanchnic Aneurysms: How I Do It |
Robyn Macsata, MD |
| 4:45 p.m. |
Complex IVC Filter Removal: Tips and Tricks |
John Kaufman, MD |
| 4:55 p.m. |
Clot Extraction for DVT Instead of Dissolution: How I Do It |
Matthew Recht, MD |
| 5:05 p.m. |
Pediatric Vascular Procedures: When Do We Get Involved and Technical Considerations? |
Mal Sheahan, MD |
| 5:15 p.m. |
More on Pediatrics! Pediatric Dialysis Procedures |
Vincent Rowe, MD |
| 5:25 p.m. |
Debate: Transfemoral Carotid Stenting is Still Relevant and This is Why! |
Chris Metzger, MD |
| 5:35 p.m. |
Debate: Not So Fast! TCAR Has Made Transfemoral Carotid Stenting Obsolete |
Brian DeRubertis, MD |
| 5:45 p.m. |
Resident Competition: “The $10,000 Pyramid” |
|
| 6:25 p.m. |
Closing Talk: |
Peter Schneider, MD |
| 6:40 p.m. |
Adjourn |
|
| 7:00 p.m. |
Closing Dinner |
|
